Marshall Wace’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.8M Buy
382,738
+372,527
+3,648% +$34M 0.03% 482
2026
Q1
$379K Buy
+10,211
New +$327K ﹤0.01% 2572
2024
Q4
Sell
-662,125
Closed -$8.51M 2537
2024
Q3
$8.51M Buy
+662,125
New +$9.57M 0.01% 816
2024
Q1
Sell
-93,227
Closed -$2.47M 2394
2023
Q4
$2.47M Buy
+93,227
New +$2.72M ﹤0.01% 1134
2023
Q2
Sell
-87,601
Closed -$2.72M 2411
2023
Q1
$2.72M Buy
87,601
+55,110
+170% +$1.78M 0.01% 1289
2022
Q4
$653K Buy
32,491
+8,376
+35% +$179K ﹤0.01% 2262
2022
Q3
$340K Buy
+24,115
New +$325K ﹤0.01% 2896

Other funds holding AEHR

Marshall Wace's AEHR Position: Q2 2026 in Review

Marshall Wace increased its Aehr Test Systems (AEHR) stake by 3,648% in Q2 2026, buying an estimated $34M and bringing the position to 382,738 shares worth $36.8M. The position accounts for 0.03% of the portfolio, ranked #482.

Marshall Wace first reported a position in AEHR in Q3 2022 and has held it in 7 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Marshall Wace held 382,738 shares of Aehr Test Systems worth $36.8M as of Q2 2026.
  • Marshall Wace bought 372,527 Aehr Test Systems shares in Q2 2026, an estimated $34M.
  • Aehr Test Systems made up 0.03% of Marshall Wace's portfolio in Q2 2026, its #482 holding.
  • Marshall Wace first reported a position in Aehr Test Systems in Q3 2022 and has held it in 7 quarters since.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.